Abbott Laboratories Articles

Tokyo pharma stocks - week to Jan 19

26 January 2004

Abbott buy of i-STAT clears hurdle

26 January 2004

Stock Commentary - New York

26 January 2004

Brazil wins major HIV/ AIDS drug price cuts

26 January 2004

Australian Minister accuses USA over PBS

19 January 2004

Highlights of pharmaceutical mergers and acquisitions during 2003

5 January 2004

Abbott Labs' Humira marks first successful year

5 January 2004

Abbott's diagnostic plant in "substantial FDA-conformity"

5 January 2004

Euro neuropathic pain products market to reach $1.7B by 2012: study

5 January 2004

Abbott Labs to acquire TheraSense in $1.2 billion deal

30 November 2003

Skye's zileuton deal with Critical Thera

30 November 2003

GSK and BI to seek only 5% royalty rate on South African ARV licenses

22 December 2003

Sanofi-Synthelabo wins UK marketing award

22 December 2003

Australian supermarket seeking to sell Rx drugs

8 December 2003

US market developments in 2002-3 and the rise of generics; CBI meeting

8 December 2003

Reliant gets US rights to Rythmol

8 December 2003

UPDATE - Celltech shares plunge on Pfizer decision, big pharma tough on UK biotechs

24 November 2003

Abbott ends diabetes collab with Karo

24 November 2003

Executive moves at France's Fournier, as firm commits to independence

24 November 2003

Abbott to study D-receptor activation in chronic kidney disease

24 November 2003

Industry welcomes govt report to boost UK bioscience, but is it enough?

24 November 2003

CAT takes Abbott to court over Humira

24 November 2003

Australian PBS "safe from US trade deal"

10 November 2003

Abbott to market Dabur's anticancer drugs in the USA

3 November 2003

New findings show long-term RA therapy with Abbott's Humira is effective

3 November 2003

Provalis underperforms as devices business fails to deliver

3 November 2003

Stock Commentary - New York

27 October 2003

Stock Commentary - New York

20 October 2003

Abbott earnings up as core sales grow

20 October 2003

Abbott earnings up as core sales grow

20 October 2003

Positive Phase II results for Schering AG's Leukine as a Crohn's disease therapy

20 October 2003

CAT in Humira dispute

20 October 2003

Tokyo pharma stocks - week to Oct 13

20 October 2003

Amersham succumbs to $9.7 billion bid from General Electric

20 October 2003

Amersham confirms bid approach; shares leap to 18-month high

13 October 2003

Abbott files for new Humira indication

13 October 2003

ZymoGenetics deal with Abbott on human Thrombin

13 October 2003

US FDA/Customs import blitz finds 88% contained unapproved drugs

6 October 2003

Abbott to buy Integrated Vascular for $65M

6 October 2003

Abbott, Boehringer Ingelheim donate to beat MTCT of HIV

6 October 2003

CAT and Dyax expand licensing deal

29 September 2003

Patent expiries "will stall BPH drug sales during 2007-12"

29 September 2003

Together Rx enrollees top 1 million

29 September 2003

Abbott Labs invests L39M in Dartford, UK, production unit

29 September 2003

Abbott Labs names Joseph Nemmers as senior VP, diagnostics operations

29 September 2003

German drug industry investment stays high despite reform

29 September 2003

Stock Commentary - New York

22 September 2003

Kaletra shows long-term benefits in HIV

22 September 2003

Abbott's humira is cleared in the EU as a therapy for rheumatoid arthritis

22 September 2003

Abbott Labs gains UK Class A status

15 September 2003

Abbott's Depakote ER gets FDA clearance for pediatric use

15 September 2003

Axcan strikes $75M drug deal with Abbott

8 September 2003

Brazil ultimatum to HIV/AIDS drugmakers

8 September 2003

UPDATE: Alizyme and Takeda in $42 million obesity drug development deal

18 August 2003

Early-stage R&D spending up, but NMEs plummet, says report

18 August 2003

Abbott and LigoCyte sign deal

11 August 2003

Genzyme makes $600 million bid for SangStat; moves into new market

11 August 2003

Brazil warns pharma over HIV/AIDS drugs

11 August 2003

Medarex recruits Steven Fischkoff as VP clinical sciences

4 August 2003

Vertex/GlaxoSmithKline's 433908 does not achieve primary goal in Ph III study

4 August 2003

Schering AG's Leukine may compensate for Yasmin generics, says Morgan Stanley

4 August 2003

EMEA supports Abbott's Synagis for use in pediatric CHD cases of RSV

4 August 2003

Lilly gains FDA OK for new Zyprexa use

21 July 2003

Tokyo pharma stocks - week to July 14

21 July 2003

GSK's early-stage HIV drugs show promise

21 July 2003

$622 million settlement charge results in 58% profits fall for Abbott Labs

21 July 2003

Baxter/Abbott patent dispute reinstated

14 July 2003

Global blockbuster antibiotics' days are numbered, says Datamonitor report

14 July 2003

Big pharma has "long way to go" to avoid risks posed by developing world

14 July 2003

Abbott completes purchase of JOMED's business lines

7 July 2003

Abbott's Humira in early/established RA

30 June 2003

Abbott sponsors free HIV testing program

30 June 2003

Promotions at Abbott Labs

30 June 2003

Abbott's Humira in early/established RA

30 June 2003

Tokyo pharma stocks - week to June 16

23 June 2003

Latin nations secure HIV/AIDS Rx price cuts

23 June 2003

Stock Commentary - New York

16 June 2003

Promising new data for Abbott's ABT-510

16 June 2003

Abbott Labs in $210M Spinal Concepts deal

9 June 2003

Abbott raises Humira estimates

9 June 2003

Abbott moves closer to EU Humira approval

2 June 2003

Aradigm acquires Weston Intraject technology

19 May 2003

Stock Commentary - New York

12 May 2003

Abbott launches interactive RA web site

5 May 2003

J&J's drug-eluting stent Cypher approved for CAD patients in USA

5 May 2003

Hassan takes biggest pay rise in 2002 CEO compensation

28 April 2003

Stock Commentary - Tokyo

21 April 2003

Stock Commentary - New York

21 April 2003

Teva gets go-ahead for Vicoprofen generic

21 April 2003

NaPro to sell worldwide paclitaxel business

14 April 2003

Profits set to fall at Boehringer Ingelheim ahead of key product launches

14 April 2003

Abbott completes bar code initiative

7 April 2003

UK NICE to view statins, antipsychotics, etc

7 April 2003

Abbott and Karo Bio identify diabetes drug

7 April 2003

Takeda forecasts solid growth for fiscal 2003; shares continue to slide

7 April 2003

Forest Labs is BusinessWeek 50's top-performing company

31 March 2003

Biocompatibles to pay L55M after US law suit

31 March 2003

Together Rx plan not reaching US seniors?

31 March 2003

Depmsey and Herrera promoted at Abbott Labs

24 March 2003

2002 world pharma sales growth: slower but still healthy, says IMS

24 March 2003

Showing 801-900 of 1936 articles

Go to beginningPreviousNextGo to end